Evaluation of Type I Error Rates When Modeling Ordered Categorical Data in NONMEM
暂无分享,去创建一个
Mats O. Karlsson | E. Niclas Jonsson | Ulrika Wählby | M. Karlsson | E. Jonsson | Katalin Matolcsi | U. Wählby | K. Matolcsi
[1] S L Beal,et al. Population pharmacokinetic data and parameter estimation based on their first two statistical moments. , 1984, Drug metabolism reviews.
[2] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[3] D. Stram,et al. Variance components testing in the longitudinal mixed effects model. , 1994, Biometrics.
[4] Mats O. Karlsson,et al. Assessment of Type I Error Rates for the Statistical Sub-model in NONMEM , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[5] L B Sheiner,et al. Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.
[6] D R Stanski,et al. Population pharmacodynamic model for ketorolac analgesia , 1996, Clinical pharmacology and therapeutics.
[7] Laura Iavarone,et al. Population Pharmacokinetic-Pharmacodynamic Model of Craving in an Enforced Smoking Cessation Population: Indirect Response and Probabilistic Modeling , 2001, Pharmaceutical Research.
[8] L B Sheiner,et al. Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships , 1999, Clinical pharmacology and therapeutics.
[9] A. Agresti. Modelling ordered categorical data: recent advances and future challenges. , 1999, Statistics in medicine.
[10] Mats O. Karlsson,et al. Assessment of Actual Significance Levels for Covariate Effects in NONMEM , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[11] Adrian Dunne,et al. Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials , 1997 .
[12] L B Sheiner,et al. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data , 1994, Clinical pharmacology and therapeutics.
[13] D. Mould,et al. Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors , 2002, Clinical pharmacology and therapeutics.
[14] Marie Davidian,et al. Nonlinear Models for Repeated Measurement Data , 1995 .
[15] Lewis B. Sheiner,et al. The Need for Mixed-Effects Modeling with Population Dichotomous Data , 2001, Journal of Pharmacokinetics and Pharmacodynamics.